Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

NCT00676403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: placebo
DRUG: Pregabalin
DRUG: Pregabalin
DRUG: Pregabalin
DRUG: Pregabalin
DRUG: Pregabalin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.